Blockonomi

NewLimit Series C: Armstrong-Backed Longevity Startup Raises $435M

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

Targeting US$610 billion longevity market, biotech firms race to reverse ageing

AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks For Beijing-based METiS TechBio CEO Lai Tsai-ta, ageing is ...
FinanceFeeds

Brian Armstrong’s $435M Gamble Goes Beyond Crypto

The raise signals a pattern among crypto executives channeling wealth into adjacent technology sectors. Armstrong has already ...
Observer

This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials

Boston-based Life Biosciences is testing whether reprogramming human cells can slow or even reverse the effects of aging. Unsplash Life Biosciences, a Boston-based biotechnology company founded in ...
Kaleido Scope

TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming

Zhou’s study, "TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming," was recently published in Circulation. The most common cause of death worldwide is ...